FDA Inspection
Merck & Co. IncMerck & Co. Inc – FDA Inspection, Feb 23, 2015
Record Details
This FDA Inspection record concerns Merck & Co. Inc, with an inspection on February 23, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Merck & Co. Inc
- Inspection Date
- February 23, 2015
- Product Type
- Drugs
View Company Profile
ID · 29879d5e-2390-4774-bc4a-a110dbd0606e
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 917872
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 312.58(a)FDA access to sponsor records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Merck & Co. Inc
15| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2026 | Not classified | New Jersey District Office | |
| March 13, 2026 | Not classified | New Jersey District Office | |
| December 18, 2025 | Not classified | New Jersey District Office | |
| May 16, 2025 | Not classified | New Jersey District Office | |
| March 27, 2025 | Not classified | New Jersey District Office |
Other documents for Merck & Co. Inc
- FDA Inspection 1329118 - 2026-08-14
- FDA Inspection 1305632 - 2026-03-13
- FDA Inspection 1283890 - 2025-12-18
- FDA Inspection 1262774 - 2025-05-16
- FDA Inspection 1264192 - 2025-03-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.